DK3730136T3 - Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom - Google Patents
Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom Download PDFInfo
- Publication number
- DK3730136T3 DK3730136T3 DK20163104.1T DK20163104T DK3730136T3 DK 3730136 T3 DK3730136 T3 DK 3730136T3 DK 20163104 T DK20163104 T DK 20163104T DK 3730136 T3 DK3730136 T3 DK 3730136T3
- Authority
- DK
- Denmark
- Prior art keywords
- ferricitrate
- patients
- treatment
- kidney disease
- chronic kidney
- Prior art date
Links
- 208000020832 chronic kidney disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261662565P | 2012-06-21 | 2012-06-21 | |
US201361757229P | 2013-01-28 | 2013-01-28 | |
US201361800618P | 2013-03-15 | 2013-03-15 | |
US201361801050P | 2013-03-15 | 2013-03-15 | |
EP13807102.2A EP2863906B1 (en) | 2012-06-21 | 2013-06-21 | Use of ferric citrate in the treatment of chronic kidney disease patients |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3730136T3 true DK3730136T3 (da) | 2024-01-22 |
Family
ID=49769729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK20163104.1T DK3730136T3 (da) | 2012-06-21 | 2013-06-21 | Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom |
Country Status (17)
Country | Link |
---|---|
US (3) | US20130345303A1 (da) |
EP (3) | EP3730136B1 (da) |
JP (4) | JP2015535209A (da) |
KR (2) | KR20200103855A (da) |
CN (2) | CN104884055A (da) |
AU (2) | AU2013278000A1 (da) |
BR (1) | BR112014032049A2 (da) |
CA (1) | CA2876982A1 (da) |
DK (1) | DK3730136T3 (da) |
EA (1) | EA201590062A1 (da) |
ES (2) | ES2970050T3 (da) |
HK (2) | HK1210013A1 (da) |
IL (1) | IL236356A0 (da) |
MX (1) | MX2014015615A (da) |
PL (1) | PL3730136T3 (da) |
SG (2) | SG11201408521WA (da) |
WO (1) | WO2013192565A2 (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108938585A (zh) | 2009-07-21 | 2018-12-07 | 凯克斯生物制药公司 | 柠檬酸铁剂型 |
TWI653043B (zh) * | 2012-12-20 | 2019-03-11 | 瑞士商伊蘭科動物健康公司 | 新用途 |
DK3578185T3 (da) | 2013-06-05 | 2020-11-02 | Tricida Inc | Protonbindende polymerer til oral indgivelse |
ES2856261T3 (es) * | 2013-10-01 | 2021-09-27 | Fresenius Medical Care Deutschland Gmbh | Método y aparatos para determinar una pérdida diaria de hierro de un paciente |
BR112016009901A8 (pt) * | 2013-11-04 | 2020-04-14 | Keryx Biopharmaceuticals Inc | uso de citrato férrico |
WO2015110968A1 (en) * | 2014-01-23 | 2015-07-30 | Lupin Limited | Pharmaceutical grade ferric citrate and method for its production |
US10172882B2 (en) | 2014-06-22 | 2019-01-08 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
MA53106A (fr) | 2014-12-10 | 2021-09-15 | Tricida Inc | Polymères liant les protons pour administration orale |
SG11201707120PA (en) * | 2015-03-04 | 2017-09-28 | Keryx Biopharmaceuticals Inc | Use of ferric citrate in the treatment of iron-deficiency anemia |
CN104688706B (zh) * | 2015-04-01 | 2017-07-14 | 成都欣捷高新技术开发有限公司 | 一种高载药量、快速溶出的枸橼酸铁组合物及其制备方法 |
WO2016162794A1 (en) * | 2015-04-08 | 2016-10-13 | Leiutis Pharmaceuticals Pvt Ltd | Pharmaceutical compositions of ferric citrate |
WO2016162888A1 (en) * | 2015-04-09 | 2016-10-13 | Actavis Group Ptc Ehf. | Process for preparing pharmaceutical grade ferric citrate |
CN109414453B (zh) | 2016-05-06 | 2023-02-17 | 特里赛达公司 | 用于治疗酸碱失衡的组合物 |
WO2019059172A1 (ja) | 2017-09-19 | 2019-03-28 | 日本たばこ産業株式会社 | 過多月経患者及び/又は過多月経を伴う婦人科疾患を有する患者における鉄欠乏性貧血の予防及び/又は治療におけるクエン酸第二鉄の使用 |
AU2018360867A1 (en) | 2017-11-03 | 2020-04-30 | Tricida, Inc. | Compositions for and method of treating acid-base disorders |
WO2019236639A1 (en) * | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Method of treating acid-base disorders |
WO2020089227A1 (en) | 2018-10-29 | 2020-05-07 | Pharmacosmos Holding A/S | Treating iron deficiency with ferric carboxymaltose |
WO2022150623A1 (en) | 2021-01-08 | 2022-07-14 | Akebia Therapeutics, Inc. | Compounds and composition for the treatment of anemia |
WO2022251563A1 (en) | 2021-05-27 | 2022-12-01 | Keryx Biopharmaceuticals, Inc. | Pediatric formulations of ferric citrate |
CN115024495B (zh) * | 2022-06-27 | 2024-03-22 | 北京金康普食品科技有限公司 | 改善肾病患者钙磷代谢的营养组合物及其应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2261750A1 (en) * | 1996-07-19 | 1998-01-29 | Nikken Chemicals Co., Ltd. | Remedies for hyperphosphatemia |
US5753706A (en) * | 1996-12-16 | 1998-05-19 | Hsu; Chen Hsing | Methods for treating renal failure |
US8093423B2 (en) | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
CN1600302A (zh) * | 2003-09-22 | 2005-03-30 | 宝龄富锦生技股份有限公司 | 含有柠檬酸铁的医药组合物以及药用级柠檬酸铁及其制法和含有药用级柠檬酸铁的膳食营养品 |
US20060134227A1 (en) * | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Compositions including iron |
KR20080037083A (ko) | 2005-08-18 | 2008-04-29 | 글로보아시아 엘엘씨 | 약학용 등급의 유기 철 화합물, 그 용도 및 이의 제조 방법 |
AU2007205167B2 (en) * | 2006-01-06 | 2013-06-13 | Vifor (International) Ag | Methods and compositions for administration of iron |
CN101374416A (zh) * | 2006-01-30 | 2009-02-25 | 环亚有限公司 | 逆转、防止、延迟或稳定软组织钙化的方法 |
CN108938585A (zh) | 2009-07-21 | 2018-12-07 | 凯克斯生物制药公司 | 柠檬酸铁剂型 |
-
2013
- 2013-06-21 ES ES20163104T patent/ES2970050T3/es active Active
- 2013-06-21 DK DK20163104.1T patent/DK3730136T3/da active
- 2013-06-21 SG SG11201408521WA patent/SG11201408521WA/en unknown
- 2013-06-21 MX MX2014015615A patent/MX2014015615A/es unknown
- 2013-06-21 KR KR1020207024260A patent/KR20200103855A/ko not_active IP Right Cessation
- 2013-06-21 WO PCT/US2013/047134 patent/WO2013192565A2/en active Application Filing
- 2013-06-21 US US13/924,332 patent/US20130345303A1/en not_active Abandoned
- 2013-06-21 AU AU2013278000A patent/AU2013278000A1/en not_active Abandoned
- 2013-06-21 CN CN201380044271.0A patent/CN104884055A/zh active Pending
- 2013-06-21 EA EA201590062A patent/EA201590062A1/ru unknown
- 2013-06-21 EP EP20163104.1A patent/EP3730136B1/en active Active
- 2013-06-21 BR BR112014032049A patent/BR112014032049A2/pt not_active IP Right Cessation
- 2013-06-21 CN CN202110644193.4A patent/CN113244209A/zh active Pending
- 2013-06-21 ES ES13807102T patent/ES2796254T3/es active Active
- 2013-06-21 KR KR1020157001458A patent/KR102150135B1/ko active IP Right Grant
- 2013-06-21 CA CA2876982A patent/CA2876982A1/en not_active Abandoned
- 2013-06-21 EP EP13807102.2A patent/EP2863906B1/en active Active
- 2013-06-21 JP JP2015518623A patent/JP2015535209A/ja active Pending
- 2013-06-21 SG SG10201805177PA patent/SG10201805177PA/en unknown
- 2013-06-21 PL PL20163104.1T patent/PL3730136T3/pl unknown
- 2013-06-21 EP EP23219273.2A patent/EP4335436A3/en active Pending
-
2014
- 2014-04-25 US US14/262,465 patent/US20140234416A1/en not_active Abandoned
- 2014-10-24 US US14/523,656 patent/US20150079168A1/en not_active Abandoned
- 2014-12-18 IL IL236356A patent/IL236356A0/en unknown
-
2015
- 2015-10-28 HK HK15110673.6A patent/HK1210013A1/xx unknown
-
2016
- 2016-03-01 HK HK16102352.0A patent/HK1214503A1/zh unknown
-
2018
- 2018-04-10 JP JP2018075243A patent/JP2018138562A/ja active Pending
- 2018-05-08 AU AU2018203205A patent/AU2018203205B2/en not_active Ceased
-
2020
- 2020-02-25 JP JP2020029756A patent/JP2020100638A/ja active Pending
-
2022
- 2022-02-10 JP JP2022019167A patent/JP2022070945A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3730136T3 (da) | Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom | |
IL285843A (en) | Ibrutinib for use in the treatment of graft-versus-host disease | |
DK2919796T3 (da) | Brug af akkermansia til behandling af stofskiftesygdomme | |
DK3811943T3 (da) | Forbindelse til anvendelse til behandling af øjenlidelser | |
DK3329909T3 (da) | Fenfluramin til anvendelse i behandling af dravet syndrom | |
GB202012283D0 (en) | Patient support usable with bariatric patients | |
DK2734126T3 (da) | Medicinske anordninger med aftagelige drejelige kæber | |
DK3329951T3 (da) | Intravaskulær blodpumpe | |
DK2844279T3 (da) | Doseringsprogrammer til behandling af pompes sygdom | |
DK2838539T3 (da) | Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser | |
DK2827813T3 (da) | Kuldebehandlingsindretning | |
DK3040336T3 (da) | Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande | |
DK3086793T3 (da) | Anvendelse af oxygenerede cholesterolsulfater (ocs) til behandling af nyredysfunktion | |
DK3400943T3 (da) | Forbindelser til anvendelse til behandling af hjernemetastaser hos en patient med erbb2+ brystkræft | |
DK2984184T3 (da) | Anvendelse af dnq eller dnq-87 i kombination med en parp1-inhibitor til behandlingen af cancer | |
HK1212255A1 (en) | Artemisinin and its derivatives for use in the treatment of kidney disease | |
DK2688588T3 (da) | Hurtig- og langtidsvirkende immunologisk terapeutisk middel | |
SG11201601490XA (en) | Risk markers for cardiovascular disease in patients with chronic kidney disease | |
DK3363437T3 (da) | Aminoindanforbindelser og anvendelse deraf i behandling af smerte | |
FR3000491B1 (fr) | Composes utilisables dans le traitement des infections mycobacteriennes | |
NO20120892A1 (no) | Truge med integrert ledd | |
ITRM20120530A1 (it) | Compounds for use in the treatment of parasitic diseases | |
DK2869845T3 (da) | Dimert protein med tredobbelte mutationer | |
BR112014010432A2 (pt) | uso médico | |
DK2694056T3 (da) | Terapeutisk behandling |